IGHG2
IGHG2 encodes the constant region of the gamma-2 immunoglobulin heavy chain, which defines the IgG2 isotype. Immunoglobulins are membrane-bound or secreted glycoproteins produced by B lymphocytes, and IgG2 contributes to antibody-dependent protection against encapsulated bacteria. Browse Assay Genie's current range of IGHG2 research reagents below, or read on for the biology behind the target.
The IGHG2 gene product is the constant region of immunoglobulin (Ig) heavy chains of the gamma-2 type. Igs are glycoproteins made by B lymphocytes, either membrane-bound or secreted. In the recognition phase of humoral immunity, membrane-bound Igs act as receptors: binding a specific antigen triggers clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs, known as antibodies, mediate the effector phase by blocking the interaction of infectious antigens with cellular receptors through the antigen-binding region, and by eliciting effector mechanisms that lead to pathogen neutralisation through the constant region.
The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its light chain. Each Ig molecule carries two antigen-binding sites, and their high affinity for a particular antigen arises from V-(D)-J rearrangement, somatic hypermutation and affinity maturation upon antigen exposure. The constant region, in contrast, defines the isotype and its effector functions. Through its fragment crystallizable (Fc) portion it interacts with receptors on innate immune cells and with the complement system. B cells can switch isotype by class-switch recombination, moving from IgM and IgD to IgG, IgA and IgE. The IgG2 isotype, formed against polysaccharide structures on encapsulated bacteria, provides antibody-dependent protection through activation of the complement pathway.
UniProt lists the protein as secreted and as present at the cell membrane, matching the soluble and membrane-bound forms of Ig. The gene sits within the immunoglobulin heavy locus, and HGNC names it with the G2m marker designation. NCBI Gene predicts roles in antigen binding, immunoglobulin receptor binding, antibacterial humoral response and classical-pathway complement activation. Researchers studying IgG subclasses often consider IGHG2 alongside IGHG1 and IGHG4.
IGHG2 encodes the constant region of the IgG2 isotype, which contributes to the effector phase of humoral immunity and pathogen neutralisation.
IgG2 is formed against polysaccharide structures on encapsulated bacteria and gives antibody-dependent protection, making it relevant to antibacterial defence studies.
The IgG2 constant region activates the complement pathway, so IGHG2 is relevant to work on classical-pathway complement and Fc-mediated effector functions.
IGHG2 is one of the IgG constant regions that B cells use after class-switch recombination from IgM and IgD.
IGHG2 encodes the constant region of gamma-2 immunoglobulin heavy chains, defining the IgG2 isotype. This region interacts through the Fc portion with innate immune cell receptors and the complement system, and IgG2 protects against encapsulated bacteria by activating the complement pathway.
HGNC names the gene immunoglobulin heavy constant gamma 2 (G2m marker). UniProt calls the protein Immunoglobulin heavy constant gamma 2. No alternative symbols or previous names are recorded, and the protein is commonly referred to as the IgG2 heavy chain constant region.
UniProt lists IGHG2 as secreted and at the cell membrane, reflecting soluble antibodies and membrane-bound B cell receptors. The gene lies in the immunoglobulin heavy locus at 14q32.33. Mouse and rat orthologues are not given in the data supplied here.
Other immunoglobulin gamma heavy constant genes and IgG subclass targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01859; product specifications from Assay Genie datasheets.